TreeWAS – Variant ID: rs2534816

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	0.000	0.000	1.000
E10.9 Without complications	0.000	0.361	0.639
E10 Insulin-dependent diabetes mellitus	0.000	0.395	0.605
E10.1 With ketoacidosis	0.000	0.433	0.567
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.486	0.514
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.489	0.511
E10.3 With ophthalmic complications	0.000	0.491	0.509
C85.1 B-cell lymphoma, unspecified	0.000	0.502	0.498
E10.4 With neurological complications	0.000	0.503	0.497
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.508	0.492
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.511	0.489
E10.2 With renal complications	0.000	0.520	0.480
C83.3 Large cell (diffuse)	0.000	0.523	0.477
E10.5 With peripheral circulatory complications	0.000	0.546	0.454
C83.0 Small cell (diffuse)	0.000	0.565	0.435
E10.8 With unspecified complications	0.000	0.566	0.434
E10.7 With multiple complications	0.000	0.566	0.434
E10.6 With other specified complications	0.000	0.566	0.434
E10.0 With coma	0.000	0.566	0.434
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.590	0.410
C83.1 Small cleaved cell (diffuse)	0.000	0.592	0.408
C88 Malignant immunoproliferative diseases	0.000	0.597	0.403
C92 Myeloid leukaemia	0.000	0.599	0.401
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.618	0.382
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.632	0.368
C85.0 Lymphosarcoma	0.000	0.632	0.368
C91 Lymphoid leukaemia	0.000	0.641	0.359
C83.7 Burkitt's tumour	0.000	0.641	0.359
C93 Monocytic leukaemia	0.000	0.647	0.353
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.647	0.352
C95 Leukaemia of unspecified cell type	0.000	0.647	0.352
C94 Other leukaemias of specified cell type	0.000	0.647	0.352
C86 Other specified types of T/NK-cell lymphoma	0.000	0.647	0.352
C83.6 Undifferentiated (diffuse)	0.000	0.649	0.351
C83.5 Lymphoblastic (diffuse)	0.000	0.649	0.351
C83.4 Immunoblastic (diffuse)	0.000	0.649	0.351
C83.2 Mixed small and large cell (diffuse)	0.000	0.649	0.351
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.657	0.343
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.661	0.339
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.668	0.332
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.671	0.328
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.672	0.328
C92.0 Acute myeloid leukaemia	0.000	0.675	0.325
C92.1 Chronic myeloid leukaemia	0.000	0.677	0.323
C91.1 Chronic lymphocytic leukaemia	0.000	0.686	0.313
C90.2 Plasmacytoma, extramedullary	0.000	0.693	0.307
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.711	0.289
C88.7 Other malignant immunoproliferative diseases	0.000	0.711	0.289
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.711	0.289
C88.3 Immunoproliferative small intestinal disease	0.000	0.711	0.289
C88.2 Gamma heavy chain disease	0.000	0.711	0.289
C88.1 Alpha heavy chain disease	0.000	0.711	0.289
C92.9 Myeloid leukaemia, unspecified	0.000	0.712	0.287
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.712	0.287
C92.7 Other myeloid leukaemia	0.000	0.712	0.287
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.712	0.287
C92.5 Acute myelomonocytic leukaemia	0.000	0.712	0.287
C92.3 Myeloid sarcoma	0.000	0.712	0.287
C92.2 Subacute myeloid leukaemia	0.000	0.712	0.287
C90.0 Multiple myeloma	0.000	0.713	0.287
C90.3 Solitary plasmacytoma	0.000	0.726	0.274
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.734	0.266
C91.4 Hairy-cell leukaemia	0.000	0.735	0.264
C92.4 Acute promyelocytic leukaemia	0.000	0.740	0.260
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.742	0.257
C91.7 Other lymphoid leukaemia	0.000	0.742	0.257
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.742	0.257
C91.3 Prolymphocytic leukaemia	0.000	0.742	0.257
C91.2 Subacute lymphocytic leukaemia	0.000	0.742	0.257
C90.1 Plasma cell leukaemia	0.000	0.747	0.253
C93.9 Monocytic leukaemia, unspecified	0.000	0.747	0.253
C93.7 Other monocytic leukaemia	0.000	0.747	0.253
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.747	0.253
C93.2 Subacute monocytic leukaemia	0.000	0.747	0.253
C93.1 Chronic monocytic leukaemia	0.000	0.747	0.253
C93.0 Acute monocytic leukaemia	0.000	0.747	0.253
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.747	0.253
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.747	0.253
C86.4 Blastic NK-cell lymphoma	0.000	0.747	0.253
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.747	0.253
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.747	0.253
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.747	0.253
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.747	0.253
C94.7 Other specified leukaemias	0.000	0.747	0.253
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.747	0.253
C94.5 Acute myelofibrosis	0.000	0.747	0.253
C94.4 Acute panmyelosis	0.000	0.747	0.253
C94.3 Mast cell leukaemia	0.000	0.747	0.253
C94.2 Acute megakaryoblastic leukaemia	0.000	0.747	0.253
C94.1 Chronic erythraemia	0.000	0.747	0.253
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.747	0.253
C95.9 Leukaemia, unspecified	0.000	0.747	0.253
C95.7 Other leukaemia of unspecified cell type	0.000	0.747	0.253
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.747	0.253
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.747	0.253
C95.0 Acute leukaemia of unspecified cell type	0.000	0.747	0.253
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.747	0.253
C96.8 Histiocytic sarcoma	0.000	0.747	0.253
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.747	0.253
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.747	0.253
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.747	0.253
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.747	0.253
C96.3 True histiocytic lymphoma	0.000	0.747	0.253
C96.2 Malignant mast cell tumour	0.000	0.747	0.253
C96.1 Malignant histiocytosis	0.000	0.747	0.253
C96.0 Letterer-Siwe disease	0.000	0.747	0.253
C91.9 Lymphoid leukaemia, unspecified	0.000	0.751	0.248
C84.5 Other and unspecified T-cell lymphomas	0.000	0.754	0.246
C82.6 Cutaneous follicle centre lymphoma	0.000	0.761	0.238
C82.5 Diffuse follicle centre lymphoma	0.000	0.761	0.238
C82.4 Follicular lymphoma grade IIIb	0.000	0.761	0.238
C82.3 Follicular lymphoma grade IIIa	0.000	0.761	0.238
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.764	0.236
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.764	0.236
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.764	0.236
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.764	0.236
C84.3 Lymphoepithelioid lymphoma	0.000	0.764	0.236
C84.2 T-zone lymphoma	0.000	0.764	0.236
C84.1 Sezary's diease	0.000	0.764	0.236
C82.0 Small cleaved cell, follicular	0.000	0.765	0.235
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.772	0.228
C84.0 Mycosis fungoides	0.000	0.774	0.226
C82.2 Large cell, follicular	0.000	0.778	0.222
C91.0 Acute lymphoblastic leukaemia	0.000	0.781	0.219
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.786	0.214
C84.4 Peripheral T-cell lymphoma	0.000	0.790	0.209
K90 Intestinal malabsorption	0.000	0.792	0.208
C91.5 Adult T-cell leukaemia	0.000	0.792	0.207
C81 Hodgkin's disease	0.001	0.808	0.192
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.849	0.151
K90.3 Pancreatic steatorrhoea	0.000	0.850	0.149
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.850	0.149
K90.1 Tropical sprue	0.000	0.850	0.149
C81.7 Other Hodgkin's disease	0.001	0.862	0.137
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.001	0.862	0.137
C81.3 Lymphocytic depletion	0.001	0.862	0.137
C81.2 Mixed cellularity	0.001	0.862	0.137
C81.0 Lymphocytic predominance	0.001	0.865	0.134
K90.8 Other intestinal malabsorption	0.000	0.869	0.131
E10-E14 Diabetes mellitus	0.000	0.881	0.119
C81.1 Nodular sclerosis	0.001	0.891	0.108
E13 Other specified diabetes mellitus	0.000	0.905	0.095
E12 Malnutrition-related diabetes mellitus	0.000	0.915	0.085
E13.9 Without complications	0.000	0.922	0.078
E14 Unspecified diabetes mellitus	0.000	0.925	0.075
E13.8 With unspecified complications	0.000	0.931	0.068
E13.7 With multiple complications	0.000	0.931	0.068
E13.6 With other specified complications	0.000	0.931	0.068
E13.5 With peripheral circulatory complications	0.000	0.931	0.068
E13.4 With neurological complications	0.000	0.931	0.068
E13.3 With ophthalmic complications	0.000	0.931	0.068
E13.2 With renal complications	0.000	0.931	0.068
E13.1 With ketoacidosis	0.000	0.931	0.068
E13.0 With coma	0.000	0.931	0.068
E14.3 With ophthalmic complications	0.000	0.933	0.067
K90.9 Intestinal malabsorption, unspecified	0.001	0.935	0.064
E12.9 Without complications	0.000	0.939	0.061
E12.8 With unspecified complications	0.000	0.939	0.061
E12.7 With multiple complications	0.000	0.939	0.061
E12.6 With other specified complications	0.000	0.939	0.061
E12.5 With peripheral circulatory complications	0.000	0.939	0.061
E12.4 With neurological complications	0.000	0.939	0.061
E12.3 With ophthalmic complications	0.000	0.939	0.061
E12.2 With renal complications	0.000	0.939	0.061
E12.1 With ketoacidosis	0.000	0.939	0.061
E12.0 With coma	0.000	0.939	0.061
C81.9 Hodgkin's disease, unspecified	0.001	0.940	0.059
E14.4 With neurological complications	0.000	0.946	0.054
E14.7 With multiple complications	0.000	0.946	0.054
E14.6 With other specified complications	0.000	0.946	0.054
E14.5 With peripheral circulatory complications	0.000	0.946	0.054
E14.2 Withrenal complications	0.000	0.946	0.054
E14.0 With coma	0.000	0.946	0.054
E14.8 With unspecified complications	0.000	0.948	0.051
E14.1 With ketoacidosis	0.000	0.949	0.051
R31 Unspecified haematuria	0.032	0.968	0.000
K90-K93 Other diseases of the digestive system	0.000	0.974	0.026
E14.9 Without complications	0.000	0.981	0.019
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.019	0.981	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.000	0.981	0.019
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.015	0.985	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.015	0.985	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.014	0.986	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.000	0.986	0.014
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.014	0.986	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.014	0.986	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.000	0.986	0.013
K93.1 Megacolon in Chagas' disease	0.000	0.986	0.013
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.000	0.986	0.013
T42.1 Iminostilbenes	0.014	0.986	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.014	0.986	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.987	0.013
T45.0 Antiallergic and antiemetic drugs	0.013	0.987	0.000
K91.3 Postoperative intestinal obstruction	0.000	0.987	0.013
T43.2 Other and unspecified antidepressants	0.013	0.987	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.000	0.988	0.012
T46 Poisoning by agents primarily affecting the cardiovascular system	0.012	0.988	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.012	0.988	0.000
K91.1 Postgastric surgery syndromes	0.000	0.988	0.012
T43.5 Other and unspecified antipsychotics and neuroleptics	0.011	0.988	0.000
T42.0 Hydantoin derivatives	0.011	0.989	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.011	0.989	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.011	0.989	0.000
T36 Poisoning by systemic antibiotics	0.011	0.989	0.000
T39.4 Antirheumatics, not elsewhere classified	0.011	0.989	0.000
T39.2 Pyrazolone derivatives	0.011	0.989	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.011	0.989	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.011	0.989	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.011	0.989	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.011	0.989	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.011	0.989	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.010	0.989	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.010	0.989	0.000
T42.3 Barbiturates	0.010	0.989	0.000
T42.2 Succinimides and oxazolidinediones	0.010	0.989	0.000
T45.5 Anticoagulants	0.010	0.989	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.011	0.989	0.000
K91.5 Postcholecystectomy syndrome	0.000	0.989	0.010
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.010	0.990	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.010	0.990	0.000
T46.1 Calcium-channel blockers	0.010	0.990	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.010	0.990	0.000
T45.8 Other primarily systemic and haematological agents	0.010	0.990	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.010	0.990	0.000
T45.6 Fibrinolysis-affecting drugs	0.010	0.990	0.000
T45.4 Iron and its compounds	0.010	0.990	0.000
T45.3 Enzymes, not elsewhere classified	0.010	0.990	0.000
T45.2 Vitamins, not elsewhere classified	0.010	0.990	0.000
T43.6 Psychostimulants with abuse potential	0.010	0.990	0.000
T43.9 Psychotropic drug, unspecified	0.010	0.990	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.010	0.990	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.010	0.990	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.010	0.990	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.010	0.990	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.990	0.010
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.010	0.990	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.000	0.990	0.009
T46.5 Other antihypertensive drugs, not elsewhere classified	0.009	0.990	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.000	0.991	0.009
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.009	0.991	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.009	0.991	0.000
T46.7 Peripheral vasodilators	0.009	0.991	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.009	0.991	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.009	0.991	0.000
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.991	0.009
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.009	0.991	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.009	0.991	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.009	0.991	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.009	0.991	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.000	0.991	0.009
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.008	0.992	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.008	0.992	0.000
T47.7 Emetics	0.008	0.992	0.000
T47.6 Antidiarrhoeal drugs	0.008	0.992	0.000
T47.5 Digestants	0.008	0.992	0.000
T47.4 Other laxatives	0.008	0.992	0.000
T47.3 Saline and osmotic laxatives	0.008	0.992	0.000
T47.2 Stimulant laxatives	0.008	0.992	0.000
T47.0 Histamine H(2)-receptor antagonists	0.008	0.992	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.008	0.992	0.000
T36.0 Penicillins	0.008	0.992	0.000
T40.5 Cocaine	0.008	0.992	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.008	0.992	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.008	0.992	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.008	0.992	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.008	0.992	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.008	0.992	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.008	0.992	0.000
T44.0 Anticholinesterase agents	0.008	0.992	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.008	0.992	0.000
T36.9 Systemic antibiotic, unspecified	0.008	0.992	0.000
T36.8 Other systemic antibiotics	0.008	0.992	0.000
T36.7 Antifungal antibiotics, systemically used	0.008	0.992	0.000
T36.6 Rifamycins	0.008	0.992	0.000
T36.5 Aminoglycosides	0.008	0.992	0.000
T36.4 Tetracyclines	0.008	0.992	0.000
T36.3 Macrolides	0.008	0.992	0.000
T36.2 Chloramphenicol group	0.008	0.992	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.008	0.992	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.992	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.008	0.992	0.000
T37.5 Antiviral drugs	0.008	0.992	0.000
T37.4 Anthelminthics	0.008	0.992	0.000
T37.3 Other antiprotozoal drugs	0.008	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.992	0.000
T37.1 Antimycobacterial drugs	0.008	0.992	0.000
T37.0 Sulphonamides	0.008	0.992	0.000
T41.5 Therapeutic gases	0.008	0.992	0.000
T41.4 Anaesthetic, unspecified	0.008	0.992	0.000
T41.3 Local anaesthetics	0.008	0.992	0.000
T41.2 Other and unspecified general anaesthetics	0.008	0.992	0.000
T41.1 Intravenous anaesthetics	0.008	0.992	0.000
T41.0 Inhaled anaesthetics	0.008	0.992	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.008	0.992	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.008	0.992	0.000
T48.5 Anti-common-cold drugs	0.008	0.992	0.000
T48.4 Expectorants	0.008	0.992	0.000
T48.3 Antitussives	0.008	0.992	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.008	0.992	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.008	0.992	0.000
T48.0 Oxytocic drugs	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.008	0.992	0.000
T49.8 Other topical agents	0.008	0.992	0.000
T49.7 Dental drugs, topically applied	0.008	0.992	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.992	0.000
T49.5 Ophthalmological drugs and preparations	0.008	0.992	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.992	0.000
T49.3 Emollients, demulcents and protectants	0.008	0.992	0.000
T49.2 Local astringents and local detergents	0.008	0.992	0.000
T49.1 Antipruritics	0.008	0.992	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.992	0.000
H65.2 Chronic serous otitis media	0.008	0.992	0.000
T39.0 Salicylates	0.008	0.992	0.000
T40.6 Other and unspecified narcotics	0.008	0.992	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.008	0.992	0.000
E05.8 Other thyrotoxicosis	0.000	0.992	0.008
T50.8 Diagnostic agents	0.008	0.992	0.000
T50.7 Analeptics and opioid receptor antagonists	0.008	0.992	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.008	0.992	0.000
T50.5 Appetite depressants	0.008	0.992	0.000
T50.4 Drugs affecting uric acid metabolism	0.008	0.992	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.008	0.992	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.008	0.992	0.000
T50.1 Loop [high-ceiling] diuretics	0.008	0.992	0.000
T50.0 Mineralocorticoids and their antagonists	0.008	0.992	0.000
H65 Nonsuppurative otitis media	0.008	0.992	0.000
N10 Acute tubulo-interstitial nephritis	0.008	0.992	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.992	0.007
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.992	0.008
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.993	0.007
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.007	0.993	0.000
T40.8 Lysergide [LSD]	0.007	0.993	0.000
T40.7 Cannabis (derivatives)	0.007	0.993	0.000
T40.3 Methadone	0.007	0.993	0.000
T40.1 Heroin	0.007	0.993	0.000
T40.0 Opium	0.007	0.993	0.000
E05.5 Thyroid crisis or storm	0.000	0.993	0.007
E05.4 Thyrotoxicosis factitia	0.000	0.993	0.007
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.993	0.007
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.993	0.007
R40.2 Coma, unspecified	0.000	0.993	0.007
T50.9 Other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.000	0.993	0.007
M45.X2 Ankylosing spondylitis (Cervical region)	0.007	0.993	0.000
T38.1 Thyroid hormones and substitutes	0.006	0.993	0.000
M45 Ankylosing spondylitis	0.007	0.993	0.000
I65.2 Occlusion and stenosis of carotid artery	0.000	0.993	0.007
T38.9 Other and unspecified hormone antagonists	0.006	0.993	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.993	0.000
T38.7 Androgens and anabolic congeners	0.006	0.993	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.006	0.993	0.000
T38.5 Other oestrogens and progestogens	0.006	0.993	0.000
T38.4 Oral contraceptives	0.006	0.993	0.000
T38.2 Antithyroid drugs	0.006	0.993	0.000
T38.0 Glucocorticoids and synthetic analogues	0.006	0.993	0.000
T39.1 4-Aminophenol derivatives	0.007	0.993	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.993	0.006
H65.0 Acute serous otitis media	0.006	0.994	0.000
T40.4 Other synthetic narcotics	0.006	0.994	0.000
E00-E07 Disorders of thyroid gland	0.000	0.994	0.006
E16 Other disorders of pancreatic internal secretion	0.000	0.994	0.006
E16.2 Hypoglycaemia, unspecified	0.000	0.994	0.006
E40-E46 Malnutrition	0.000	0.994	0.006
H65.1 Other acute nonsuppurative otitis media	0.006	0.994	0.000
D23.6 Skin of upper limb, including shoulder	0.000	0.994	0.006
N32.3 Diverticulum of bladder	0.006	0.994	0.000
H65.4 Other chronic nonsuppurative otitis media	0.005	0.995	0.000
H65.3 Chronic mucoid otitis media	0.005	0.995	0.000
Z94.8 Other transplanted organ and tissue status	0.000	0.995	0.005
T40.2 Other opioids	0.005	0.995	0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.005	0.995	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.005	0.995	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.005	0.995	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.005	0.995	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.005	0.995	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.005	0.995	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.005	0.995	0.000
E15 Nondiabetic hypoglycaemic coma	0.000	0.995	0.005
Z88.2 Personal history of allergy to sulphonamides	0.000	0.995	0.005
R30-R39 Symptoms and signs involving the urinary system	0.005	0.995	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.995	0.005
E00 Congenital iodine-deficiency syndrome	0.000	0.995	0.005
E27.1 Primary adrenocortical insufficiency	0.000	0.995	0.005
K91.4 Colostomy and enterostomy malfunction	0.000	0.995	0.004
E46 Unspecified protein-energy malnutrition	0.000	0.995	0.004
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.995	0.004
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.995	0.004
E16.4 Abnormal secretion of gastrin	0.000	0.995	0.004
E16.3 Increased secretion of glucagon	0.000	0.995	0.004
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.996	0.004
H65-H75 Diseases of middle ear and mastoid	0.004	0.996	0.000
K42.9 Umbilical hernia without obstruction or gangrene	0.004	0.996	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.996	0.004
E45 Retarded development following protein-energy malnutrition	0.000	0.996	0.004
E43 Unspecified severe protein-energy malnutrition	0.000	0.996	0.004
E42 Marasmic kwashiorkor	0.000	0.996	0.004
E41 Nutritional marasmus	0.000	0.996	0.004
E40 Kwashiorkor	0.000	0.996	0.004
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.001
N41.0 Acute prostatitis	0.004	0.996	0.000
R30 Pain associated with micturition	0.004	0.996	0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.000	0.996	0.004
K25 Gastric ulcer	0.000	0.996	0.004
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.996	0.004
R33 Retention of urine	0.004	0.996	0.000
N41.1 Chronic prostatitis	0.004	0.996	0.000
E16.1 Other hypoglycaemia	0.000	0.996	0.004
K25.7 Chronic without haemorrhage or perforation	0.000	0.996	0.004
R30.0 Dysuria	0.004	0.996	0.000
E07 Other disorders of thyroid	0.000	0.996	0.004
H73 Other disorders of tympanic membrane	0.004	0.996	0.000
T42.4 Benzodiazepines	0.004	0.996	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.004	0.996	0.000
H70 Mastoiditis and related conditions	0.004	0.996	0.000
J32.9 Chronic sinusitis, unspecified	0.004	0.996	0.000
J32.2 Chronic ethmoidal sinusitis	0.004	0.996	0.000
E27 Other disorders of adrenal gland	0.000	0.996	0.004
R36 Urethral discharge	0.004	0.996	0.000
N41 Inflammatory diseases of prostate	0.004	0.996	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.996	0.003
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.996	0.003
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.996	0.003
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.996	0.003
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.996	0.003
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.996	0.003
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.996	0.003
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.996	0.003
H66 Suppurative and unspecified otitis media	0.004	0.996	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.996	0.004
E06 Thyroiditis	0.000	0.996	0.003
E50-E64 Other nutritional deficiencies	0.000	0.996	0.003
H69 Other disorders of Eustachian tube	0.003	0.996	0.000
E65-E68 Obesity and other hyperalimentation	0.000	0.996	0.003
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.003	0.997	0.000
H68 Eustachian salpingitis and obstruction	0.003	0.997	0.000
H67 Otitis media in diseases classified elsewhere	0.003	0.997	0.000
E44.1 Mild protein-energy malnutrition	0.000	0.997	0.003
E44.0 Moderate protein-energy malnutrition	0.000	0.997	0.003
I20.8 Other forms of angina pectoris	0.003	0.997	0.000
H92.0 Otalgia	0.003	0.997	0.000
R35 Polyuria	0.003	0.997	0.000
R30.9 Painful micturition, unspecified	0.003	0.997	0.000
H70.8 Other mastoiditis and related conditions	0.003	0.997	0.000
J32 Chronic sinusitis	0.003	0.997	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.000	0.997	0.003
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.000	0.997	0.003
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.000	0.997	0.003
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.000	0.997	0.003
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.000	0.997	0.003
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.000	0.997	0.003
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.000	0.997	0.003
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.000	0.997	0.003
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.000	0.997	0.003
K25.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.997	0.003
K25.2 Acute with both haemorrhage and perforation	0.000	0.997	0.003
K25.1 Acute with perforation	0.000	0.997	0.003
H66.3 Other chronic suppurative otitis media	0.003	0.997	0.000
E20 Hypoparathyroidism	0.000	0.997	0.003
H66.2 Chronic atticoantral suppurative otitis media	0.003	0.997	0.000
K25.4 Chronic or unspecified with haemorrhage	0.000	0.997	0.003
H70.1 Chronic mastoiditis	0.003	0.997	0.000
E11 Non-insulin-dependent diabetes mellitus	0.000	0.997	0.003
E07.1 Dyshormogenetic goitre	0.000	0.997	0.003
E07.0 Hypersecretion of calcitonin	0.000	0.997	0.003
J32.0 Chronic maxillary sinusitis	0.003	0.997	0.000
E27.9 Disorder of adrenal gland, unspecified	0.000	0.997	0.003
H73.1 Chronic myringitis	0.003	0.997	0.000
H73.0 Acute myringitis	0.003	0.997	0.000
E07.8 Other specified disorders of thyroid	0.000	0.997	0.003
E20.9 Hypoparathyroidism, unspecified	0.000	0.997	0.003
G45.4 Transient global amnesia	0.000	0.997	0.003
K25.5 Chronic or unspecified with perforation	0.000	0.997	0.003
N41.9 Inflammatory disease of prostate, unspecified	0.003	0.997	0.000
H66.4 Suppurative otitis media, unspecified	0.003	0.997	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.997	0.003
H70.2 Petrositis	0.003	0.997	0.000
H70.0 Acute mastoiditis	0.003	0.997	0.000
J32.1 Chronic frontal sinusitis	0.003	0.997	0.000
R34 Anuria and oliguria	0.003	0.997	0.000
K25.3 Acute without haemorrhage or perforation	0.000	0.997	0.003
R30.1 Vesical tenesmus	0.003	0.997	0.000
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.000	0.997	0.003
E27.5 Adrenomedullary hyperfunction	0.000	0.997	0.003
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.997	0.003
E27.0 Other adrenocortical overactivity	0.000	0.997	0.003
E29 Testicular dysfunction	0.000	0.997	0.003
H71 Cholesteatoma of middle ear	0.003	0.997	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.000	0.997	0.003
N41.8 Other inflammatory diseases of prostate	0.003	0.997	0.000
N41.3 Prostatocystitis	0.003	0.997	0.000
N41.2 Abscess of prostate	0.003	0.997	0.000
H66.0 Acute suppurative otitis media	0.003	0.997	0.000
D25.9 Leiomyoma of uterus, unspecified	0.003	0.997	0.000
H73.8 Other specified disorders of tympanic membrane	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations